Corrigendum to "Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients".

Для цитирования: Karapetyan Lilit, Kuriakose Joel, DiMaggio Elizabeth, Ward Kimberly, Chau Jamie, Otteni Christopher, Kalos Denise, Ali Johannes, Hall MacLean S, Beatty Matthew, Klinkova Olga V, Alomar Mohammed E, Gaskill Eric E, Gonzalez Rebecca M, Bailey Hanna, Yu Michael, Tran Nam, Rodriguez-Alfonso Lianicet, Vieira Ella, Adams Karla, Jain Michael, Locke Frederick L, Baldonado Jobelle, Perez Matthew C, Mullinax John, Zager Jonathan S, Gonzalez Ricardo, Sondak Vernon K, Markowitz Joseph, Brohl Andrew S, Eroglu Zeynep, Tarhini Ahmad A, Khushalani Nikhil I, Mulé James J, Sarnaik Amod A, Pilon-Thomas Shari. Corrigendum to "Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients".. Transplantation and cellular therapy. 2026. DOI: 10.1016/j.jtct.2026.09.032.